Axsome Therapeutics
New York, US · Founded 2012
Biotech
Founders & leadership
HT
Herriot TabuteauExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$2.5MraisedMay 2015 · 14 investors · Pharmaceuticals
Rule 506(b)$1.3MraisedJan 2015 · 4 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.